Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: ECC:CDNX - EPS Capital Corporation

No earlier versions found for this Subject.

Return to ECC:CDNX - EPS Capital Corporation

Here is one to watch for - they are in clinical trials for a new Multiple Sclerosis treatment which already shows huge strides forward over any other drug out there. The current drug treatment is highly expensive and has tremendous side affects. It is claimed that this new treatment shows no side affects and shows tremendous potential in not just slowing the onslaught of MS but rather to halt it. The treatment is being developed in Canada.